Total Payments
$2,005
2024 Payments
$1,114
Companies
25
Transactions
96
Medicare Patients
3,451
Medicare Billing
$248,620
Payment Breakdown by Category
Food & Beverage$1,734 (86.5%)
Education$152.24 (7.6%)
Gifts$118.80 (5.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,734 | 85 | 86.5% |
| Education | $152.24 | 9 | 7.6% |
| Gift | $118.80 | 2 | 5.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mannkind Corporation | $449.15 | 14 | $0 (2024) |
| Novo Nordisk Inc | $284.11 | 19 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $207.02 | 10 | $0 (2024) |
| Medtronic, Inc. | $152.32 | 3 | $0 (2024) |
| Vifor Pharma, Inc. | $134.69 | 6 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $122.24 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $103.97 | 6 | $0 (2024) |
| Insulet Corporation | $89.80 | 4 | $0 (2024) |
| Travere Therapeutics, Inc. | $85.66 | 5 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $48.71 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,114 | 54 | Otsuka America Pharmaceutical, Inc. ($207.02) |
| 2023 | $441.18 | 20 | MannKind Corporation ($273.24) |
| 2022 | $318.40 | 12 | Mannkind Corporation ($151.92) |
| 2021 | $16.32 | 1 | Merck Sharp & Dohme Corporation ($16.32) |
| 2020 | $26.59 | 2 | AstraZeneca Pharmaceuticals LP ($26.59) |
| 2019 | $23.40 | 2 | AstraZeneca Pharmaceuticals LP ($12.50) |
| 2018 | $12.90 | 1 | SANOFI-AVENTIS U.S. LLC ($12.90) |
| 2017 | $52.77 | 4 | SANOFI-AVENTIS U.S. LLC ($24.91) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.91 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $9.87 | General |
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: NEPHROLOGY | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: NEPHROLOGY | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Obesity | ||||||
| 10/31/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $23.42 | General |
| Category: NEPHROLOGY | ||||||
| 10/29/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.59 | General |
| 10/28/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/22/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/17/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Hyperkalemia | ||||||
| 10/10/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $15.43 | General |
| Category: Insulin Pump | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: NEPHROLOGY | ||||||
| 10/07/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $22.38 | General |
| Category: NEPHROLOGY | ||||||
| 10/02/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Nephrology | ||||||
| 09/25/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $18.09 | General |
| Category: NEPHROLOGY | ||||||
| 09/23/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $23.50 | General |
| Category: Insulin Pump | ||||||
| 09/19/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.07 | General |
| 09/13/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Obesity | ||||||
| 09/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Hyperkalemia | ||||||
| 08/30/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,346 | 1,814 | $283,765 | $80,890 |
| 2022 | 19 | 1,077 | 1,329 | $225,695 | $68,268 |
| 2021 | 5 | 434 | 651 | $151,871 | $51,326 |
| 2020 | 7 | 594 | 794 | $117,626 | $48,136 |
Total Patients
3,451
Total Services
4,588
Medicare Billing
$248,620
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 281 | 512 | $138,240 | $41,358 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 169 | 169 | $70,304 | $19,079 | 27.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 51 | 51 | $26,469 | $7,470 | 28.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 123 | 168 | $11,592 | $2,756 | 23.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 231 | 316 | $5,688 | $2,597 | 45.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 125 | 168 | $6,216 | $1,480 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 26 | $4,758 | $1,375 | 28.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 106 | 143 | $5,720 | $1,342 | 23.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 73 | 81 | $3,483 | $817.65 | 23.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 35 | 38 | $2,090 | $498.56 | 23.9% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 11 | 11 | $1,859 | $444.95 | 23.9% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 16 | 16 | $1,696 | $404.64 | 23.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 43 | 49 | $1,568 | $372.89 | 23.8% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 20 | 22 | $1,518 | $355.83 | 23.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 12 | 12 | $1,452 | $348.12 | 24.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 15 | $942.00 | $135.33 | 14.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 17 | 17 | $170.00 | $54.57 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 218 | 322 | $86,940 | $28,363 | 32.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 101 | 101 | $52,419 | $15,821 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $27,456 | $7,537 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 64 | $11,712 | $4,222 | 36.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 33 | $11,946 | $4,089 | 34.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 92 | 112 | $7,728 | $1,838 | 23.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $3,794 | $1,018 | 26.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 87 | 105 | $3,885 | $924.74 | 23.8% |
About Dr. Douglas Gresham, M.D
Dr. Douglas Gresham, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Savannah, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629155676.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Gresham, M.D has received a total of $2,005 in payments from pharmaceutical and medical device companies, with $1,114 received in 2024. These payments were reported across 96 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,734).
As a Medicare-enrolled provider, Gresham has provided services to 3,451 Medicare beneficiaries, totaling 4,588 services with total Medicare billing of $248,620. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Savannah, GA
- Active Since 11/01/2006
- Last Updated 03/02/2010
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629155676
Products in Payments
- AFREZZA (Drug) $449.15
- JYNARQUE (Drug) $207.02
- MINIMED 780G (Device) $136.09
- Veltassa (Drug) $134.69
- Rybelsus (Drug) $129.34
- RAYALDEE (Drug) $122.24
- Omnipod (Device) $89.80
- Wegovy (Drug) $76.08
- Ozempic (Drug) $61.54
- FARXIGA (Drug) $55.60
- AIRSUPRA (Drug) $48.37
- SOLIQUA (Drug) $37.81
- TARPEYO (Drug) $37.56
- VOQUEZNA (Drug) $33.47
- JANUVIA (Drug) $30.96
- JARDIANCE (Drug) $29.79
- Dexcom G6 Transmitter (Medical Supply) $24.60
- Kerendia (Drug) $21.31
- ACTHAR (Biological) $19.45
- LUPKYNIS (Drug) $18.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Savannah
Ismary Decastro, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $241,309
Endocrinology, Diabetes & Metabolism $241,309
Joseph Dehaven, M D, M D
Endocrinology, Diabetes & Metabolism — Payments: $224,445
Endocrinology, Diabetes & Metabolism $224,445
Kaveh Ehsanipoor, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $109,441
Endocrinology, Diabetes & Metabolism $109,441
Dr. James Stoever, D.o, D.O
Endocrinology, Diabetes & Metabolism — Payments: $24,329
Endocrinology, Diabetes & Metabolism $24,329
Carolyn Nelson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $17,059
Endocrinology, Diabetes & Metabolism $17,059
Priti Nath, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $2,258
Endocrinology, Diabetes & Metabolism $2,258